Clinical trial
High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
NCT02960607
Study timeline
Study start (unknown)2016-11-01Date precision: month
Registry last updated2016-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Non-Small-Cell Lungunresolved
Interventions
IcotinibDRUG
Sponsors & collaborators
Chinese Academy of Medical Scienceslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02960607 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.